NEW DELHI :
Work in AI breast cancer treatment is going on and Dr Khalid Raza has bagged Rs 94 lakh ICMR grant for AI breast cancer treatment..
The Indian Council of Medical Research (ICMR) has selected Dr Raza and his team for a research grant of nearly ₹94 lakh for breast cancer treatment.
The funding is given to him for his earlier contributions to using Artificial Intelligence (AI) in drug design.
Dr Raza is Associate Professor in the Department of Computer Science, Jamia Millia Islamia.
AI breast cancer treatment: Dr Raza achievement
This grant is expected to play an important role in advancing innovative research aimed at using AI to develop precise and effective treatments for breast cancer.
Now, Dr Raza and his team will focus on developing advanced tools for AI-driven drug design. Their work will center on optimising drug compounds, pinpointing therapeutic targets, and creating innovative treatment strategies for breast cancer.
One such promising drug compound, DdpMPyPEPhU, already patented by Dr. Raza will be further explored under this initiative.
This research tackles key challenges in breast cancer treatment and is poised to deliver transformative results that could have a global impact on healthcare practices.
Both Professor Mazhar Asif, Vice-Chancellor of Jamia, and Professor Md Mahtab Alam Rizvi, Registrar, congratulated Dr Raza on his outstanding achievement.
“This is a moment of great pride for Jamia. Dr. Raza’s recognition by ICMR highlights the university’s dedication to promoting research excellence and innovation,” said the VC.
Groundbreaking work in AI breast cancer treatment
His groundbreaking work showcases Jamia’s vital contributions to integrating AI in healthcare research, said VC Asif.
Dr Raza said: “I am honoured to be selected for this ICMR grant. This is an opportunity to further our research in AI-driven drug design and make a meaningful contribution to improving health outcomes for millions. I am deeply grateful to my research team, collaborators, and ICMR for their continuous support.”
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment. This initiative aligns closely with ICMR’s mission to support cutting-edge research addressing India’s critical healthcare challenges.
AI breast cancer treatment: Dr Raza a distinguished researcher
Dr Raza is a distinguished researcher in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
Award and grants are not something new for Dr Raza. Stanford University recognised him among the world’s top 2 per cent scientists from 2021-2023.
Dr Raza has served in various academic and administrative roles at Jamia.
He has published over 140 research articles in prestigious journals, conference proceedings, 14 authored/edited books, and held notable positions, including ICCR Chair Visiting Professor of Computer and Information Sciences at Ain Shams University, Egypt, and is an honorary research fellow at INTI International University, Malaysia.
Dr Raza also serves as Associate Editor for PeerJ Computer Science and Guest Editor for esteemed journals like npj Precision Oncology, Natural Product Communications, and Mini-Reviews in Medicinal Chemistry. His remarkable contributions to the scientific community and Jamia are truly remarkable!
This grant represents a convergence of excellence, with the potential to revolutionise breast cancer treatment and affirm Jamia’s status as a hub for transformative research.
source: http://www.okhlatimes.com / The Okhla Times / Home> JMI/EDU / by The Okhla Times (edited) / November 30th, 2024
